BioSpace News Archive

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it has initiated the commercial launch of Hulio™, a biosimilar to AbbVie’s Humira® (adalimumab), across major markets in Europe.

The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that two student pharmacists recently completed a summer internship organized by the Foundation and supported by Allergan Plc

A new study in JAMA Network Open underscores the risk to patients if the Anthem Blue Cross Blue Shield policy to deny emergency coverage based largely on a patient’s diagnoses after a visit, is adopted nationwide.

In response to opinions expressed following the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee meeting on October 12, AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX) stands by the safety, efficacy and medical need for its investigational therapy, DSUVIA™.

Experience Canady Robotics SR-70TM Assisted Surgical System at USMI Booth #717

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration has approved Dupixent® (dupilumab

LumiThera® Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and disease, today announced that it will present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology (OIS@AAO) meeting on October 25, 2018, in Chicago, IL.

U.S. Sen. Martin Heinrich is among the dignitaries expected to attend the International Water, Sanitation and Hygiene (IWSH) Foundation’s 2018 Community Plumbing Challenge, which begins Monday in Thoreau, New Mexico.

Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, today announced that it has appointed Cindy Lynch to Vice President, General Counsel. Ms. Lynch has nearly 15 years of experience providing strategic legal and intellectual property advice to medical device startups.